Daily Stock List
CirTran Corp. (CIRC)
UltimatePennyStock and OTCPicks reported previously on CirTran Corp. (CIRC), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Salt Lake City, Utah-based CirTran Corp. providescomplete product development and manufacturing services for a wide collection of business sectors. The Company's roots are as an international, full-service contract manufacturer. CirTran operates along with their Racore Technology electronics manufacturing subsidiary. CirTran's operations include CirTran-Asiaand CirTran Beverage.In addition,CirTran Products pursues contract-manufacturing relationships in the U.S. consumer products markets. This includes licensed merchandise sold in the sports and entertainment markets.
CirTran has developedfrom their origins in the electronics industry to focus on manufacturing and marketing Playboy Energy Drinks around the world. Their CirTran Beverage has partnered with Play Beverages, LLC, to introduce and distribute the Playboy Energy Drink. In 2007, CirTran created this CirTran Beverage subsidiary, which partnered with Play Beverages, to introduce and distribute Playboy Energy Drink a year later.CirTran continues to uphold the capabilities of their previous core business.
The CirTran-Asia subsidiary has principal offices in ShenZhen, China. They manufacture high-volume electronics, fitness equipment, and household products for the multi-billion-dollar direct response industry. During 2012, CirTran established operations and gained new revenue in Asia. This included China, the Middle East, and Africa, among other areas. Operations continued in the U.S., South America, Europe and Canada. CirTran had beverage distribution operations in over 20 nations, entering this current year.
In the United States,CirTran provide a mix of high- and medium-volume turnkey manufacturing services and products using differenthigh-tech applications for leading electronics original equipment manufacturers(OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. The Company’s services include pre-manufacturing, manufacturing, and post-manufacturing services.
Beverage Distribution for CirTran was 98 percent and 94 percent of total revenue during the six months ended June 30, 2013 and 2012, respectively.Contract Manufacturing was 2 percent and 6 percent of total revenue during the six months ended June 30, 2013 and 2012, respectively.
CirTran Corp. (CIRC), closed at $0.0004, up 33.33%, on 8,003,994 volume with 15 trades. The average volume for the last 60 days is 23,790,922 and the stock's 52-week low/high is $0.0002/$0.0039.
World Moto, Inc. (FARE)
Pumps and Dumps, PennyStocks24, Stocktwiter, Greenbackers, OTCPicks, Penny Stocks VIP, and Real Pennies reported earlier on World Moto, Inc. (FARE), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
World Moto, Inc. manufactures and supplies taxi meters for the motorcycle taxi industry. The Company offers portable taxi meters and black boxes for motorcycles. World Moto invented the Moto-Meter, a device that CNN, Newsweek, Wired, and Moneylife, among others, are calling "the world's first motorcycle taxi meter" and "world's first portable taxi meter" and "first-ever black box for motorcycles." World Moto has their headquarters in Bangkok, Thailand, and the Company’s shares trade on the OTC Bulletin Board.
In addition, the Company is the creator of Yes, the "Need it Now!" service. Commercial development of Yes began last year. The construction of the service is as a customer-centric electronic marketplace. It offers popular services on-demand (e.g., mobility and delivery) through web, phone or phone application from anywhere, at any time.
Furthermore, World Moto is the creator of Wheelies – their unique advertising product.Full commercial release of Wheelies is expected to start in mid-November 2013. The Company’s intention is to release the Wheelies product to interested parties via joint ventures with advertising agencies and exclusive licensing agreements with established moto taxi fleet operators.
Development of the Company’s Moto-Meter commenced in 2009 to professionalize the $500 billion dollar a year moto taxi industry. The Moto-Meter is the first taxi meter designed specifically for the large motorcycle taxi market. Main features of the product include a device that is portable, tamperproof, ruggedized, and insect resistant.
The Moto-Meter incorporates GPS and MEMS technology to calculate fares and serves as a black box that records important data. This includes speed, acceleration and braking information. The LED screen displays "infotainment" and geographically relevant ads, including nearby shops and restaurants, for the duration of the ride. The ads can garner revenue for the driver and World Moto.
In addition,World Moto is working to adapt the Moto-Meter so that it can pass all current and anticipated regulatory requirements of INMETRO, the National Institute of Metrology for Brazil, and other international regulatory agencies.
World Moto, Inc. (FARE), closed Wednesday’s session at $0.0421, up 2.68%, on 255,560 volume with 19 trades. The average volume for the last 60 days is 382,771 and the stock's 52-week low/high is $0.0301/$2.50.
Dussault Apparel, Inc. (DUSS)
PennyStocks24 and Fast Moving Stocks reported earlier on Dussault Apparel, Inc. (DUSS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Dussault Apparel, Inc. is a designer and licensor of high-end quality apparel. The Company’s product line includes custom designed hoodies, jewelry, t-shirts, as well as hats. Dussault Apparel has their corporate headquarters in South Pasadena, Florida. The Company’s shares trade on the OTC Markets’ OTCQB. The Company incorporated on October 1, 2006 in the State Nevada under the name Release Your Lease, Inc.
Their initial business plan was to create a web-based service for buyers and sellers of leased automobiles. Their new management subsequently changed the corporate direction of the Company to pursue opportunities in the retail fashion industry.Effective June 11, 2007,they completed a merger with their wholly owned subsidiary Dussault Apparel, Inc. Consequently, Dussault Apparelpresently operates in the retail fashion industry. Their Management is currently looking for other acquisition opportunities to build additional revenue streams for the Company, if possible.
Dussault Apparel involves in the licensing of their Deuce collection of apparel in Canada and the United States. They design apparel, such as hats and T-shirts; hoodies and headwear; and skateboards and swimwear for promotional events. In addition, the Company sells limited edition prints of artwork via theirwebsite. They sell their products through retail stores, upscale retailers, boutiques, as well as specialty stores. Furthermore, they sell through their website under the Deuce Custom Ink brand name.
Specific products include Men’s Deuce T Shirts and Women’s Deuce T Shirts. They also includeSaumurai Panda (Black) Hoodies and Foo Dog (Black) Hoodies.
During the three month periods ended July 31, 2013 and 2012 respectively, Dussault Apparel earned gross revenues and gross profits of $187 in comparison to $3,313. During the three month period ended July 31, 2013, the Company recorded a net loss of $25,692 in comparison to a net loss of $71,791 for the three month period ended July 31, 2012; this was due to a reduction in operational costs.
Dussault Apparel, Inc. (DUSS), closed Wednesday’s trading session at $0.0015, up 50.00%, on 7,328,922 volume with 35 trades. The average volume for the last 60 days is 1,683,853 and the stock's 52-week low/high is $0.0004/$0.0025.
Generex Biotechnology Corp. (GNBT)
OTCPicks, PennyTrader Publisher, and Greenbackers reported previously on Generex Biotechnology Corp. (GNBT), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Generex Biotechnology Corp. engages in the research, development, and commercialization of drug delivery systems and technologies. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity - with no deposit in the lungs. Their proprietary liquid formulations allow drugs typicallyadministered by injection to undergo absorption into the body via the lining of the inner mouth using their proprietary RapidMist™ device. The Company's buccal insulin spray product, Generex Oral-lyn™, is in Phase III clinical trials at a number of sites globally.
Antigen Express, Inc. is a wholly owned subsidiary of Generex Biotechnology. Antigen Express is a platform technology and product-based company. The core platform technologies of Antigen Express consist of immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, as well as autoimmune diseases.Antigen Express is developing proprietary vaccine formulations for active immunotherapy and disease prevention.
Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One technology focuses on modification of peptides with Ii-Key to increase potency. A second technology relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for strongstimulation of T-helper cells and prevents the further growth of cancer cells.
Generex is actively seeking prospective partners for the Phase III trial of the Antigen Express AE37 breast cancer vaccine. Antigen Express is currently in a late Phase IIb trial of the novel cancer vaccine AE37 to prevent relapse in patients who have had breast cancer.
The Company’sRapidMist™ is an advanced buccal drug delivery technology. Itconsists of a proprietary formulation and a proprietary device design that can deliver drugs via the buccal mucosa safely. RapidMist™ has been shown to have a rapid onset of action with no lung deposition, precise dosage control, easy use and handling, as well as improved patient compliance.
Generex BioTechnology’sGenerex Oral-lyn™ is an insulin spray for the treatment of Type I and Type II diabetes. Generex Oral-lyn™ is a safe, simple, fast, effective, and pain-free alternative to subcutaneous injections of prandial insulin. It is conveniently delivered to the membranes of the oral cavity by a straightforwardasthma-like device with no pulmonary (lung) deposition.
Generex Biotechnology Corp. (GNBT), closed today at $0.0329, up 8.58%, on 1,365,331 volume with 39 trades. The average volume for the last 60 days is 2,340,067 and the stock's 52-week low/high is $0.02/$0.07.
Pazoo, Inc. (PZOO)
MoneyTV, Wallstreetlivechat, FeedBlitz, and SmallCapVoice reported earlier on Pazoo, Inc. (PZOO), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2010, Pazoo, Inc. delivers information, services, and products by way of direct response digital and TV, retail stores, and their website. Their www.pazoo.com site is a health and wellness social community. Pazoo focuses on empowering individuals with the tools to enrich their lives. Pazoo was founded by Mr. David M. Cunic, a successful physical therapist and personal trainer.Pazoo is based inCedar Knolls, New Jersey.
Pazoo focuses on delivering easy-to-understand information and on competitively priced products through relationships with leading vendors in the health improvement and pet supplies industries. The Company’s team of medical, fitness, nutritional, and pet experts’ works to enhance their customers' wellbeing through presenting a limited, but high quality selection of merchandise. These include fitness consumables, nutritional supplements, apparel, as well as wellness/safety products for pets.
Pazoo hasteamed up with award winning fitness distributor Acacia. Acacia is an RLJ Entertainment, Inc. brand (RLJE). Acacia has agreed to supply Pazoo with health and wellness videos and content. This will enhance the website and provide important information to the Pazoo audience. Acacia is a leading producer of original and award-winning yoga, fitness, and wellness DVD programming. Pazoo will feature clips from an assortment of Acacia's acclaimed instructors.
In September,Pazoo reported that two more advertising providers are being added to www.pazoo.com. This brings several thousand more advertisers to the website. These new advertising agencies will be adding different types of advertising products. This includes the higher earning Rich/Enhanced Media. Where the Rich Media is placed on the site will result in eCPMs for the Rich Media to enhancean expected $1.25, up 100 percent from the approximately $0.60 Pazoo currently sees in those spots. The eCPM for Video ads will jump 66 percent from $3.00 to $5.00.
Last week,Pazoo announced the signing of Celebrity Chef Eric LeVine. Chef LeVine will be the lead Pazoo Cooking Expert on Pazoo.com. He will supply Pazoo and their millions of visitors’ healthy recipes and cooking advice concerning how to make exquisite food that is healthy at the same time.
Pazoo, Inc. (PZOO), closed Wednesday’s session at $0.022, up 5.77%, on 640,509 volume with 20 trades. The average volume for the last 60 days is 382,115 and the stock's 52-week low/high is $0.0104/$0.134.
The Graystone Company, Inc. (GYST)
MassiveStockProfits, Super Hero Stocks, Shiznit Stocks, PennyStocks24, Mad Money Picks, Stock Shock and Awe, Fast Money Alerts, and Penny Stock General reported earlier on The Graystone Company, Inc. (GYST), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Las Vegas, Nevada, The Graystone Company, Inc. is a mining and exploration company concentrating on acquiring and developing gold and other mineral properties. Their strategy involves the identification, acquisition, and exploration of early-stage properties that show significant potential for the discovery of gold. The Company’s shares trade on the OTC Markets’ OTCQB.
The Company's Natural Resources Division locates and extracts mineral deposits for refiningvia the acquirement of properties where proven or probable mineral ore reserves have already been discovered. Graystoneemploys a diversity of mining methods to maximize their search for gold and other precious metals. These methods include placer mining, sluice box mining, trammel mining, and deposits – including residual, alluvial, and bench deposits.Graystone does not engage in general exploration activities.
The Graystone Company has their Gorilla Project. This project consists of 400 hectares located in Loreto, Peru (Northern Peru). The Gorilla Project operation involves alluvial mining of gold from the deposits of sand and gravel usually left from modern or ancient streambeds. The Company also has their Graystone II project. This project consists of 800 hectares located in Loreto, Peru. This property is next to their Gorilla Project.
In addition, the Company has their Graystone III project. This project consists of 700 hectares located in Amazonas, Peru (Northern Peru). The property is approximately 3.5 hours north from their project Gorilla and Graystone II.The Company's mining operations in Peru consist of alluvial (or placer) mining.
Last week,The Graystone Company announced that their mining operations in Peru generated approximately 240-260 grams per month for the months of June, July, and August 2013 for approximately 750 grams. The Company has doubled their production since April 2013 when they produced approximately 130 grams. The Graystone Company has completed this phase of testing and has determined that it is economically feasible to acquire an excavator and additional heavy machinery for Peru.
Today,The Graystone Companyannounced an update on their Suriname mining operation. The Company entered into two new prospecting contracts in Suriname. One is for 200 hectares (Suriname 2); the second one is for 2,400 hectares (Suriname 3). They are prospecting these properties with their joint venture (JV) partner and local operator. The Suriname operations are conducted as a joint venture where Graystone owns 40 percent of the JV.
The Graystone Company, Inc. (GYST), closed today at $0.0115, even for the day, on 3,880,704 volume with 69 trades. The average volume for the last 60 days is 10,791 and the stock's 52-week low/high is $0.01/$47.50.
PURE Bioscience, Inc. (PURE)
Wallstreetlivechat, SmarTrend Newsletters, MissionIR, Investor News Source, Tiny Gems, and Greenbackers reported earlier on PURE Bioscience, Inc. (PURE), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Based in El Cajon, California, PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to many global health challenges. These include Staph (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. The Company is the creator of the patented silver dihydrogen citrate (SDC) antimicrobial. PURE Bioscience's proprietary high efficacy/low toxicity bioscience technologies (including the silver dihydrogen citrate-based antimicrobials) represent innovative advances in diversemarkets and lead today's worldwide trend toward industry and consumer use of "green" products. This is while providing competitive advantages in efficacy and safety.
The Patented SDC is an electrolytically generated source of stabilized ionic silver. It formulates well with other compounds. PURE's patented SDC is the first new antimicrobial in decades. SDC can serve as the foundation for a wide array of products in different markets. It is colorless, odorless, tasteless, as well as non-caustic. The Company produces and markets pre-formulated, ready-to-use product, and varying strengths of SDC concentrate as an additive or raw material for inclusion in other products.
PURE's products include SDC-Based Hard Surface Disinfectant. SDC is the basis for the EPA registered hard surface disinfectant, PURE™ Hard Surface. SDC is highly toxic to bacteria, fungus and virus; it is non-toxic to humans and animals. SDC kills microorganisms through two methodsof action. The silver ion deactivates structural and metabolic membrane proteins leading to microbial death. Moreover, the microbes view SDC as a food source, allowing the silver ion to enter the microbe. Once inside the organism, the silver ion denatures the DNA. This halts the microbe's ability to replicate and leads to its death.
EPA-registered PURE™ Hard Surface disinfectant and food contact surface sanitizer provides a combination of high efficacy and low toxicity; it features 30-second bacterial kill times and 24-hour residual protection. PURE™ Hard Surface totallykills resistant pathogens such as MRSA. In addition, it effectively eliminates dangerous fungi and viruses; these include HIV, Norovirus, Influenza A, Avian Influenza, and H1N1.
Last week,PURE Bioscienceannounced the appointment of Mr. William Otis to their Board of Directors. Mr. Otis is the sixth member to join PURE’s Board of Directors. He is currently the President and COO of Patrick Cudahy, LLC and Saratoga Food Specialties. Both companies are food manufacturing companies of John Morrell Food Group and Smithfield Foods.
PURE Bioscience, Inc. (PURE), closed Wednesday’ssession at $1.26, up 7.69%, on 238,883 volume with 126 trades. The average volume for the last 60 days is 107,403 and the stock's 52-week low/high is $0.2203/$1.20.
Nano Labs Corp. (CTLE)
PennyStocks24, Pumps and Dumps, Stock Trader, and Black Tie Stock Alerts reported recently on Nano Labs Corp. (CTLE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Nano Labs Corp.is a nanotechnology research and development company that lists on the OTC Bulletin Board.Their research and development team of scientists, designers, and engineers concentrates on creating a portfolio of advanced products that could provide benefits to many industries. These include consumer products, energy, materials, and healthcare.Nanotechnology is already at use in electronics, medicine, cosmetics, textiles, biomaterials, and energy production.Founded in 2012, Nano Labs has their headquarters in Detroit, Michigan.
The Company’s head of research and development is Professor Victor Castano. He is a renowned scientist in nanotechnology. He has devoted approximately 30 years to nanotechnology after receiving his Doctorate in Science (Physics) from Universidad Nacional Autónoma de México (UNAM). This is the only university in Mexico with Nobel Prize laureates among its alumni. Dr. Castano has extensive knowledge in physics, chemistry, and mathematics. He has taught and has conducted research at UNAM; he is presently a member of the faculty at the Center for Applied Physics and Advanced Technology at UNAM.
Recently,Nano Labs reported on Exova's BTU test results of the Company's proprietary Nanotech Gasoline (NG).Exova performed the ASTM D-240, the Standard Test Method for Heat of Combustion, using a Parr Calorimeter. The heat of combustion, as determined by this test method, is designated as one of the chemical and physical requirements of both commercial and military turbine fuels and aviation gasolines.
Exova reported BTU values of 35,659 kJ/kg for Nano Lab's NG, in comparison to 'Regular' gasoline at 41,134 kJ/kg.The Nanotech Gasoline (NG) combines 60 percent commercial grade gasoline with 40 percent ordinary drinking water, plus Nano Labs’ proprietary nanotechnology.
Last week,Nano Labs announced that they signed a Collaboration Agreement with Soluciones Nanotecnologicas, S.L., (Nanotex(R)) Spain to launch an Industrial Applications Development Program (IADP) to design and develop new industrial applications suitable for commercialization of "nano scale magnetic particles."Nanotex(R) is a spin-out company of the Solutex Group.
The Collaboration Agreement outlines the establishment of a joint work group to create a consistent product that addresses the growing market share globally in the nano tech magnetics industry.The Companies will work together to develop and commercialize nanomagnetic technology, patents, utility models, and industrial designs, for industrial and commercial applications.
Nano Labs Corp. (CTLE), closed Wednesday’s trading session at $0.0252, up 0.80%, on 690,812 volume with 45 trades. The average volume for the last 60 days is 1,006,452 and the stock's 52-week low/high is $0.0018/$1.52.
First Titan Corp. (FTTN)
The QualityStocks Daily Newsletter would like to spotlight First Titan Corp. (FTTN). Today, First Titan Corp. closed trading at $1.04, off by 0.95%, on 58,274 volume with 40 trades. The stock’s average daily volume over the past 60 days is
68,493, and its 52-week low/high is
First Titan Corp. announced today that, as they continue exploring assets to add to their growing oil and gas portfolio, the company is evaluating a new play in South Texas with the potential for significant cash flow and resulting share price appreciation. The site being targeted is a 1,000-acre patch of gas wells in Willacy County. The 3D seismic driven prospect promises shallow gas production with the potential for attractive financial returns for FTTN and its investors.
First Titan Corp. (FTTN), is currently focused on exploring and developing oil and natural gas resources in the southern region of the United Sates, but has a worldwide growth strategy in place. The company continually seeks to partner with energy developers that are pursuing innovative new methods of oil and gas extraction, including the development of new technologies, cleaner methods, and unconventional resources.
First Titan has acquired multiple working interests with established oil exploration companies to deliver new hydrocarbons to an ever-growing market. As the company maintains drilling activities at its acquisition in South Lake Charles, Louisiana, it is looking to continue adding to its asset base that includes five new wells along the Gulf Coast, from West Texas to Alabama.
Global demand for energy is rising fast as the vehicle populations of emerging nations such as China, Brazil, and India continue to soar. U.S. exports of petroleum products have reached 2.6 million barrels a day, which is double the level of three years ago. As demand for global energy resources rises, the U.S. is poised to become an international supplier.
New innovations in drilling and rising global demand have positioned First Titan as a premier early-stage company with strong growth potential. By utilizing cutting-edge technology to extract oil and gas resources, the company is able to recover fossil fuels that were once considered too difficult or too expensive to recover. Disclaimer
First Titan Corp. Company Blog
First Titan Corp. News:
FTTN Exploring Big Money Play in South Texas
FTTN Invests into Lucrative Gas-to-Liquids Market
FTTN Assets Positioned for Big Gains
eCrypt Technologies, Inc. (ECRY)
The QualityStocks Daily Newsletter would like to spotlight eCrypt Technologies, Inc. (ECRY). Today, eCrypt Technologies, Inc. closed trading at $0.17, off by 4.97%, on 14,410 volume with 4 trades. The stock’s average daily volume over the past 60 days is 15,042 and its 52-week low/high is $0.055/$0.28.
eCrypt Technologies, Inc. announced today that ECRY co-founder and CEO Brad Lever has completed a new and exclusive interview with Small Cap Stock Newsletter aggregator QualityStocks, a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report. The new audio interview with eCrypt Technologies, Inc. is now available online at the following link (http://qualitystocks.net/interview-ecry.php).
eCrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. eCrypt is the trusted first choice for those looking to keep their communications confidential.
Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.
The flagship eCrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using eCrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.
eCrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer
eCrypt Technologies, Inc. Blog
eCrypt Technologies, Inc. News:
eCrypt Technologies, Inc. CEO Featured in Exclusive QualityStocks Interview
eCrypt Focuses on Immediately Addressable Market
eCrypt Technologies Receives Patent Pending Status
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.165, off by 5.44%, on 872,045 volume with 133 trades. The stock’s average daily volume over the past 60 days is 674,191, and its 52-week low/high is $0.13/$0.41.
International Stem Cell Corp. announced today that they revealed the latest results from their Parkinson's disease program at the American Neurological Association's 2013 Annual Meeting recently. Neural stem cells potentially provide therapeutic benefit through multiple mechanisms of action including migration to the site of injury, secretion of neurotrophic factors, immunomodulation, cell replacement, and finally recovery of the endogenous neurons. This new data obtained as part of ISCO's collaboration with the Sanford Burnham Medical Research Institute establishes a solid foundation for the clinical use of neural stem cells for the treatment of Parkinson's diseases.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces New Data From Parkinson's Disease Program
International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
International Stem Cell Corporation to Present New Data From Parkinson's Disease Program at the American Neurological Association 2013 Annual Meeting
Boston Therapeutics, Inc. (BTHE)
The QualityStocks Daily Newsletter would like to spotlight Boston Therapeutics, Inc. (BTHE). Today, Boston Therapeutics, Inc. closed trading at $1.00, on 4,389 volume with 4 trades. The stock’s average daily volume over the past 60 days is 14,581, and its 52-week low/high is $0.15/$1.48.
Boston Therapeutics, Inc. announced today that they will be presenting a corporate update at the Livingston Securities Advanced and Nano Life Sciences Summit on October 17, in New York City. Kenneth A. Tassey, Jr., President of Boston Therapeutics, will be addressing the Company's product pipeline, including PAZ320, a non-systemic chewable therapeutic compound at 2:50 PM ET and will go over the company's product for reducing post-meal glucose elevation, as well as some corporate developments. The presentation will also be available on Boston Therapeutics' website (http://ir.stockpr.com/bostonti/overview).
Boston Therapeutics, Inc. (BTHE) is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs. An IP portfolio solidifies the company's position in the pharmaceutical industry. Boston Therapeutics' current product pipeline, PAZ320 and IPOXYNT, is comprised of therapies developed to treat patient populations with Type 2 diabetes.
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrate in foods during digestion. Boston Therapeutics believes PAZ320 is a safe and effective drug compound for people with pre-diabetes and diabetes in their daily management of blood glucose levels, fulfilling an unmet medical need. PAZ320 has completed a Phase ll clinical trial at Dartmouth Medical Center. 45% of the patients responded with a 40% reduction in the elevation of post meal blood sugar compared to baseline with no serious adverse events.
IPOXYNT, a universal oxygen carrier, is an injectable Rx for prevention of necrosis and treatment of ischemic conditions which may lead to necrosis. This compound is not a biologic, but a second generation New Chemical Entity HBOC (hemoglobin based oxygen carrier). The potential for this product goes well beyond Lower Limb Ischemia into a range of areas from anemia and blood loss (injury), to cardiovascular disease and surgical blood supplementation.
The Boston Therapeutics management and advisory team has extensive expertise in complex carbohydrate chemistry, regulatory affairs, and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration. Backed by a team with more than five decades of expertise in public and private business management, the company is well positioned to advance its status as a premier developer of complex carbohydrate-based new chemical entities. Disclaimer
Boston Therapeutics, Inc. Company Blog
Boston Therapeutics, Inc. News:
Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota
Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
Max Sound Corp. (MAXD)
The QualityStocks Daily Newsletter would like to spotlight Max Sound Corp. (MAXD). Today, Max Sound Corp. closed trading at $0.25, up 15.74%, on 256,510 volume with 40 trades. The stock’s average daily volume over the past 60 days is 253,300, and its 52-week low/high is $0.165/$0.50.
Max Sound Corp. (MAXD) is an HD Audio Technology company with proprietary software that significantly improves the sound quality from virtually any digital or analog source - without increasing file size. Leveraging a strategic software licensing business model, MAX-D’s market is vast and includes improving recorded music, movies, audio books, live streaming, televised events, video games, television network programming, and all audio on mobile devices.
Through Max Sound’s recent acquisition of Liquid Spins, MAX-D has aligned its Technology with a significant audience who purchase music through smart devices. Liquid Spins is a digital media distribution company that has contracts with all major record labels in the United States, and specializes in targeted marketing strategies that focus on selling music in areas where music is not currently sold.
Backed by seasoned management, a competitive advantage, and strong intellectual properties, the company’s MAX-D Audio Process is poised to revolutionize the way consumers listen to media and communicate on their mobile devices. The MAX-D Technology restores audio to the highest quality in real time, while maximizing the output potential of virtually any device - without requiring any equipment change or upgrade in infrastructure.
Consumers have become unaware that they are listening to inferior compressed audio – in much the same way that HD television opened our eyes to a better picture quality, MAX-D opens our ears, to a realistic, true to life listening experience. MAX-D™ is Audio Perfected. Disclaimer
Max Sound Corp. Company Blog
Max Sound Corp. News:
Max Sound Corporation to Present at Singular's 8th Annual Best of the Uncovereds Conference
Max Sound Corporation CEO Featured in Equities.com Interview
MAX-D HD Audio Technology Debuts At Qualcomm's Uplinq 2013 Wireless Ecosystem Conference
CD International Enterprises, Inc. (CDII)
The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.0861, up 7.63%, on 584,954 volume with 38 trades. The stock’s average daily volume over the past 60 days is 141,811, and its 52-week low/high is $0.041/$0.205.
CD International Enterprises, Inc. (CDII) is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas, in addition to providing business and financial consulting services. Headquartered in Deerfield Beach, Florida, with corporate offices in Shanghai, CD International Enterprises’ unique infrastructure provides a platform to expand business opportunities globally.
Through its wholly owned subsidiary, International Magnesium Group, CD International Enterprises owns and operates one of the leading producers of magnesium in the world. International Magnesium Group sources its magnesium from six production facilities in the People's Republic of China, with a combined annual production and distribution capacity of approximately 80,000 metric tons of magnesium ingots and 10,000 metric tons of magnesium powder.
CD International Enterprises also sources, aggregates, and distributes iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China via wholly owned subsidiary CDII Minerals. The scope of CDII Minerals’ services include: purchasing, financing, logistics, quality control, in addition to conducting comprehensive legal, financial, and technical due diligence on suppliers.
The company’s management team possesses the necessary leadership expertise and a solid working knowledge of the unique characteristics of business operations in the U.S., China, Mexico, and South America. Employing a global growth strategy, CD International Enterprises has the unique ability to identify emerging market opportunities and provide comprehensive solutions or services relevant to conducting cross border business. Disclaimer
CD International Enterprises, Inc. Company Blog
CD International Enterprises, Inc. News:
CD International Subsidiary Completes Initial Shipments of Bolivian Iron Ore to a Leading Metals Trading Company in China
Minera MAPSA Completes Transfer of 178,000 Acres of Mining Concessions in Peru to CD International Enterprises Subsidiary
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of CD International Enterprises, Inc.
Midwest Energy Emissions Corp. (MEEC)
The QualityStocks Daily Newsletter would like to spotlight Midwest Energy Emissions Corp. (MEEC). Today, Midwest Energy Emissions Corp. closed trading at $0.68, up 3.03%, on 15,669 volume with 9 trades. The stock’s average daily volume over the past 60 days is 10,130, and its 52-week low/high is $0.15/$1.30.
Midwest Energy Emissions Corp. (MEEC) develops and delivers patented, cost-effective mercury capture systems and technologies to power plants and other coal-burning units in the United States and Canada. As a result of the company’s innovative, patented mercury removal technologies, customers can attain compliance with new, highly restrictive government emissions regulations, in the most effective and economical manner.
In 2011, the EPA issued its Mercury and Air Toxics Standards (MATS) for power plants. The new rule is intended to reduce air emissions of heavy metals, including mercury (Hg), from all major U.S. power plants. It is projected that the total national cost of this mandate will reach $9.6 billion annually. More than a dozen states have established even more stringent emission limits, further increasing demand for energy emission control technology.
Leveraging its partnership with University of North Dakota’s Energy & Environment Research Center (EERC), the premier center of mercury control research, Midwest Energy Emissions is well positioned to meet and exceed new government regulations with its exclusive patent rights to EERC’s mercury control technology. The company’s customer-centric mercury capture solutions use a combination of materials tailored specifically to customers’ coal-fired units.
Years of research and testing with the EERC has enabled Midwest Energy to deliver one of the most effective low-cost and high-capture solutions possible – typically without impacting operations or requiring extensive capital equipment changes. The total mercury solution offered by Midwest Energy Emissions is uniquely formulated to optimize mercury capture at any coal-fired unit. Disclaimer
Midwest Energy Emissions Corp. Company Blog
Midwest Energy Emissions Corp. News:
Midwest Energy Emissions Corp. SEA™ Technology Featured in Energy-Tech Magazine
Midwest Energy Emissions Corp. to Partake as Partnering Sponsor of the Energy and Environmental Research Center Air Quality IX Conference
Midwest Energy Emissions Corp. Engagement of QualityStocks Investor Relations Services
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0054, even for the day. The stock’s average daily volume over the past 60 days is 259,426, and its 52-week low/high is $0.0035/$0.12.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Inc. and The Alternative Initiate New Brand Development Project
Consorteum Holdings Inc. Forms a New, Wholly Owned Subsidiary
Consorteum Holdings, Inc. Appoints Olde Monmouth Stock Transfer Company as New Transfer Agent
Today's Top 3
Pumps and Dumps
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
- Boston Therapeutics, Inc. (BTHE) to Present at the Livingston Securities Advanced and Nano Life Sciences Summit
- CD International Enterprises, Inc. (CDII) Subsidiary Completes Initial Shipments of Bolivian Iron Ore to a Leading Metals Trading Company in China
- Calpian, Inc. (CLPI) Money-on-Mobile Serves Over 71 Million Users
- Consorteum Holdings, Inc. (CSRH) Forms a New, Wholly Owned Subsidiary
- DoMark International, Inc. (DOMK) Increases Holding in Imagic Ltd. Ahead of SmartLink Global Launch
- eCrypt Technologies, Inc. (ECRY) CEO Featured in Exclusive QualityStocks Interview
- Epazz Inc. (EPAZ) Revenues Increase Over 1,000 Percent Since Going Public
- First Titan Corp. (FTTN) Exploring Big Money Play in South Texas
- GlobalWise Investments, Inc. (GWIV) to Participate at the 2013 OPRA Fall Conference
- Intelimax Media, Inc. (IXMD) Launches New Daily Fantasy Sports Platform on DraftTeam.com
- International Stem Cell Corp. (ISCO) Announces New Data From Parkinson's Disease Program
- Mabwe Minerals Inc. (MBMI) Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification
- Max Sound Corp. (MAXD) to Present at Singular's 8th Annual Best of the Uncovereds Conference
- Midwest Energy Emissions Corp. (MEEC) SEA™ Technology Featured in Energy-Tech Magazine
- NanoTech Entertainment, Inc. (NTEK) Joins HDCP Licensee Group
- Nexus Enterprise Solutions, Inc. (NXES) Catapults into Profitability
- On The Move Systems Corp. (OMVS) Acquires Stake in Luxury Transportation Company
- OxySure Systems, Inc. (OXYS) Launches OxySure Commercial Finance
- PITOOEY!, Inc. (PTOO) Providing Mobile Web Platform for Frys.com Open
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification
- Sohm, Inc. (SHMN) CEO Featured in Exclusive QualityStocks Interview
- Singlepoint, Inc. (SING) and Linkstorm Form Strategic Alliance to Expand Singlepoint's Global Presence
- StreamTrack, Inc. (STTK) Announces Cancellation of Potential $2.5 Million Royalty Liability
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement